Clinical Characteristics and Influencing Factors of Ankylosing Spondylitis with Hypo-high-density Lipoproteinemia
1.Department of TCM Rheumatology,Beijing Key Lab for Immune-mediated Inflammatory Diseases,China-Japan Friendship Hospital,Beijing 100029,China
2.Evidence-based Medicine Center,Beijing University of Chinese Medicine,Beijing 100029,China
*Corresponding author:TAO Qingwen,Professor,Chief physician;E-mail:taoqg1@sina.com
LI Dongxia,CHEN Yingying,HAN Mei, et al. Clinical Characteristics and Influencing Factors of Ankylosing Spondylitis with Hypo-high-density Lipoproteinemia [J]. Chinese General Practice, 2019, 22(20): 2422-2425. DOI: 10.12114/j.issn.1007-9572.2018.00.401.
李冬霞,陈颖颖,韩梅等. 强直性脊柱炎合并低高密度脂蛋白血症的临床特征及影响因素分析[J]. 中国全科医学, 2019, 22(20): 2422-2425. DOI: 10.12114/j.issn.1007-9572.2018.00.401.
[1]BIRTANE M.Pitfalls and progress in the assessment of function and functioning in ankylosing sponylitis[J].Turk J Rheumatol,2013,28(4):223-225.DOI:10.5606/tjr.2013.09513.
[2]孙海阁,刘挺榕,罗甜甜,等.高密度脂蛋白心血管保护作用新进展:功能及机制[J].解放军医学杂志,2014,39(11):908-911.DOI:10.11855/j.issn.0577-7402.2014.11.13.
SUN H G,LIU T R,LUO T T,et al.Progress of cardioprotective effects of high density lipoprotein:function and mechanism[J].Medical Journal of Chinese People's Liberation Army,2014,39(11):908-911.DOI:10.11855/j.issn.0577-7402.2014.11.13.
[3]VAN HALM V P,VAN DENDEREN J C,PETERS M J,et al.Increased disease activity is associated with a deteriorated lipid profile in patients with ankylosing spondylitis[J].Ann Rheum Dis,2006,65(11):1473-1477.DOI:10.1136/ard 2005.050443.
[4]VAN HALM V P,NIELEN J M M,NURMOHAMED M T,et al.Lipids and inflammation:serial measurements of the lipid profile of blood donors who later developed rheumatoid arthritis[J].Ann Rheum Dis,2007,66(2):184-188.DOI:10.1136/ard 2006.051672.
[5]VAN DER LINDEN S,VALKENBURG H A,CATS A.Evaluation of diagnostic criteria for ankylosing spondylitis:a proposal for modification of the New York criteria[J].Arthritis Rheum,1984,27(4):361- 368.DOI:10.1002/art.1780270401.
[6]戴璟,闵杰青,杨云娟.中国九省市成年人血脂异常流行特点研究[J].中华心血管病杂志,2018,46(2):114-118.DOI:10.3760/cma.j.issn.0253-3758.2018.02.009.
DAI J,MIN J Q,YANG Y J.A study on the epidemic characteristics of dyslipidemia in adults of nine provinces of China[J].Chinese Journal of Cardiology,2018,46(2):114-118.DOI:10.3760/cma.j.issn.0253-3758.2018.02.009.
[7]中国成人血脂异常防治指南修订联合委员会.中国成人血脂异常防治指南(2016年修订版)[J].中华健康管理学杂志,2017,11(1):7-28.DOI:10.3760/cma.j.issn.1674-0815.2017.01.003.
Joint Committee Issued Chinese Guideline for the Management of Dyslipidemia in Adults.2016 Chinese guideline for the management of dyslipidemia in adults[J].Chinese Journal of Health Management,2017,11(1):7-28.DOI:10.3760/cma.j.issn.1674-0815.2017.01.003.
[8]吴珊珊,段振华.强直性脊柱炎流行病学研究进展[J].安徽医科大学学报,2013,48(8):988-992.
WU S S,DUAN Z H.Progress in epidemiology of ankylosing spondylitis[J].Acta Universitatis Medicinalis Anhui,2013,48(8):988-992.
[9]邓玉玲,严谨,王秀华,等.长沙市46000名职工血脂状况调查与影响因素分析[J].护理学报,2016,23(6):41-44.DOI:10.16460/j.issn1008-9969.2016.06.041.
DENG Y L,YAN J,WANG X H,et al.Lipid level of 46,000 staff in Changsha and its influence factors[J].Journal of Nursing(China),2016,23(6):41-44.DOI:10.16460/j.issn1008-9969.2016.06.041.
[10]中华医学会风湿病学分会.强直性脊柱炎诊断及治疗指南[J].中华风湿病学杂志,2010,14(8):557-559.DOI:10.3760/ cma.j.issn.1007-7480.2010.08.012.
Chinese Medical Association for Rheumatology.Guidelines for the diagnosis and treatment of ankylosing spondylitis[J].Chinese Journal of Rheumatology,2010,14(8):557-559.DOI:10.3760/cma.j.issn.1007-7480.2010.08.012.
[11]蒋娟,熊小敏,张卫云,等.人白细胞抗原HLA-B27在强直性脊柱炎中的临床意义[J].生物技术通讯,2014,25(3):410-411.DOI:10.3969/j.issn.1009-0002.2014.03.026.
JIANG J,XIONG X M,ZHANG W Y,et al.Clinical value of HLA-B27 in ankylosing spondylitis[J].Letters in Biotechnology,2014,25(3):410-411.DOI:10.3969/j.issn.1009-0002.2014.03.026.